Conclusions Telemonitoring interventions may be a better option than usual care in improving glycated haemoglobin control of patients with type 2 diabetes .
Aims This study evaluated clinical effectiveness of telemonitoring on the management of patients with type 2 diabetes .
Telemedicine in the Management of Type 2 Diabetes Mellitus
Objective To explore a model of Internet‐based integrated management of diabetes , we established a remote diabetes medical service platform ( U‐Healthcare ) and evaluated its effectiveness and practicality . Material s and Methods In total , 212 patients with type 2 diabetes mellitus were r and omly assigned to 2 groups . Data from the intervention group were automatically transmitted through a glucometer ; furthermore , this group received information regarding medicines , diet , exercise and other management through U‐Healthcare . The control group received conventional medical treatment without any additional intervention . All patients were regularly followed up every 3 months for half a year . Results At the 3‐month follow‐up , fasting plasma glucose levels of the intervention group were significantly lower than those at the baseline as well as those of the control group . Triglyceride levels of the intervention group were much lower than those at the baseline . At the 6‐month follow‐up , 2‐hour postpr and ial plasma glucose levels of the intervention group significantly improved compared with those of the control group . HbA1c levels gradually decreased every 3 months in the intervention group , and the mean change in the levels was significantly greater in this group than in the control group ( from 1.27‐0.68 % ) . At the end of the study , more than 80 % of the patients in the intervention group adhered to blood glucose monitoring 2‐3 days per week , and their compliance degree was 72 % . Conclusions The Internet‐based U‐Healthcare system of integrated management in diabetes not only achieved better glycemic control , effectively improved HbA1c levels and decreased triglyceride levels but also enhanced patients ’ adherence to the medical team 's instructions
Conclusions Telemonitoring interventions may be a better option than usual care in improving glycated haemoglobin control of patients with type 2 diabetes .
Aims This study evaluated clinical effectiveness of telemonitoring on the management of patients with type 2 diabetes .